v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenues $ 2,249 $ 332
Costs of revenues 1,440 340
Gross profit (loss) 809 (8)
Operating expenses:      
Research and development, net 28,564 12,794 22,012
Sales and marketing 1,814 1,063 1,933
General and administrative 3,709 1,093 1,187
Total operating expenses 34,087 14,950 25,132
Operating loss 33,278 14,958 25,132
Financial expenses, net 24,814 667 475
Net loss $ 58,092 $ 15,625 $ 25,607
Basic and diluted loss per share attributable to Ordinary Shareholders (in Dollars per share) $ 2.64 $ 1.7 $ 2.87
Weighted-average number of shares used in computing basic and diluted loss per share attributable to Ordinary Shareholders (in Shares) [1] 22,027,292 9,205,169 8,910,561
[1] Prior period share and per share information has been retroactively adjusted to reflect the 1:46.25783 stock split and the changes in par value from NIS 0.01 to NIS 0.000216 effected on October 7, 2021. See also Note 12, Share Capital, for details.

Source